Humana Inc. (NYSE:HUM) Shares Sold by Prudential PLC

Prudential PLC trimmed its holdings in shares of Humana Inc. (NYSE:HUMFree Report) by 27.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 22,465 shares of the insurance provider’s stock after selling 8,458 shares during the quarter. Prudential PLC’s holdings in Humana were worth $10,285,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. First Financial Corp IN boosted its stake in shares of Humana by 7.2% in the 4th quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock valued at $157,000 after buying an additional 23 shares during the period. Walker Financial Services Inc. lifted its stake in Humana by 3.9% during the fourth quarter. Walker Financial Services Inc. now owns 795 shares of the insurance provider’s stock worth $364,000 after purchasing an additional 30 shares during the last quarter. Signaturefd LLC lifted its stake in Humana by 1.2% during the fourth quarter. Signaturefd LLC now owns 2,634 shares of the insurance provider’s stock worth $1,206,000 after purchasing an additional 30 shares during the last quarter. Brighton Jones LLC lifted its stake in Humana by 6.8% during the fourth quarter. Brighton Jones LLC now owns 470 shares of the insurance provider’s stock worth $215,000 after purchasing an additional 30 shares during the last quarter. Finally, Humankind Investments LLC lifted its stake in Humana by 3.9% during the third quarter. Humankind Investments LLC now owns 821 shares of the insurance provider’s stock worth $399,000 after purchasing an additional 31 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have commented on the company. Cantor Fitzgerald cut their price target on Humana from $391.00 to $360.00 and set a “neutral” rating on the stock in a research report on Thursday, April 25th. Jefferies Financial Group cut their price target on Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a research report on Monday, April 22nd. UBS Group cut their price target on Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a research report on Thursday, April 25th. Raymond James initiated coverage on Humana in a research report on Friday, March 22nd. They set a “market perform” rating on the stock. Finally, Wells Fargo & Company dropped their target price on Humana from $413.00 to $350.00 and set an “overweight” rating on the stock in a report on Monday, April 8th. Thirteen equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $423.63.

Read Our Latest Report on HUM

Humana Price Performance

Shares of NYSE:HUM traded down $3.63 on Friday, hitting $351.80. The company had a trading volume of 875,608 shares, compared to its average volume of 1,891,832. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. Humana Inc. has a 52-week low of $298.61 and a 52-week high of $530.54. The business has a 50 day moving average of $332.50 and a 200 day moving average of $362.56. The company has a market cap of $42.39 billion, a PE ratio of 21.91, a PEG ratio of 2.12 and a beta of 0.53.

Humana (NYSE:HUMGet Free Report) last issued its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.12 by $1.11. Humana had a return on equity of 17.76% and a net margin of 1.82%. The business had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. During the same period in the prior year, the business earned $9.38 earnings per share. The business’s revenue was up 10.7% on a year-over-year basis. As a group, equities analysts anticipate that Humana Inc. will post 16 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.54 annualized dividend and a yield of 1.01%. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Humana Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

See Also

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.